Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Defenses Against Pathogens and Herbivores02:26

Defenses Against Pathogens and Herbivores

Plants present a rich source of nutrients for many organisms, making it a target for herbivores and infectious agents. Plants, though lacking a proper immune system, have developed an array of constitutive and inducible defenses to fend off these attacks.
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are Unique Regional Factors the Missing Link in India's COVID-19-Associated Mucormycosis Crisis?

mBio·2022
Same author

Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2022
Same author

Invasive mould infections in patients from floodwater-damaged areas after hurricane Harvey - a closer look at an immunocompromised cancer patient population.

The Journal of infection·2022
Same author

Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis.

Frontiers in immunology·2022
Same author

Candida auris Bloodstream Infection Induces Upregulation of the PD-1/PD-L1 Immune Checkpoint Pathway in an Immunocompetent Mouse Model.

mSphere·2022
Same author

Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrata.

Microbiology spectrum·2022

Related Experiment Video

Updated: May 25, 2026

Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae
10:45

Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae

Published on: July 30, 2012

Host defenses against zygomycetes.

Emmanuel Roilides1, Dimitrios P Kontoyiannis, Thomas J Walsh

  • 1Third Department of Pediatrics, Aristotle University, Hippokration Hospital, Thessaloniki, Greece. roilides@med.auth.gr

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|January 17, 2012
PubMed
Summary

Mucormycosis is a severe fungal infection linked to risk factors like immunosuppression and iron overload. This article explores the body's immune response to Zygomycetes and its effect on mucormycosis outcomes.

More Related Videos

Viability Assay of Trichoderma stromaticum Conidia Inside Human Peripheral Blood Mononuclear-Derived Macrophages
07:21

Viability Assay of Trichoderma stromaticum Conidia Inside Human Peripheral Blood Mononuclear-Derived Macrophages

Published on: October 20, 2023

A Visual Guide for Studying Behavioral Defenses to Pathogen Attacks in Leaf-Cutting Ants
08:10

A Visual Guide for Studying Behavioral Defenses to Pathogen Attacks in Leaf-Cutting Ants

Published on: October 12, 2018

Related Experiment Videos

Last Updated: May 25, 2026

Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae
10:45

Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae

Published on: July 30, 2012

Viability Assay of Trichoderma stromaticum Conidia Inside Human Peripheral Blood Mononuclear-Derived Macrophages
07:21

Viability Assay of Trichoderma stromaticum Conidia Inside Human Peripheral Blood Mononuclear-Derived Macrophages

Published on: October 20, 2023

A Visual Guide for Studying Behavioral Defenses to Pathogen Attacks in Leaf-Cutting Ants
08:10

A Visual Guide for Studying Behavioral Defenses to Pathogen Attacks in Leaf-Cutting Ants

Published on: October 12, 2018

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Mucormycosis is a serious, invasive fungal infection.
  • Key risk factors include immunosuppression, barrier breakdown, iron overload, and hyperglycemia/acidosis.
  • The host mounts an innate immune response against Zygomycetes, similar to Aspergillus infections.

Purpose of the Study:

  • To discuss the host defense mechanisms against Zygomycetes.
  • To explore strategies for augmenting host defense in mucormycosis.
  • To analyze the impact of host defense on mucormycosis outcomes.

Main Methods:

  • Review of existing literature on mucormycosis and host immunity.
  • Analysis of immune responses to Zygomycetes (sporangiospores and hyphae).
  • Discussion of factors influencing the augmentation of host defense.

Main Results:

  • The innate immune system targets Zygomycetes through specific responses.
  • Augmentation of host defense may influence disease progression.
  • Understanding these mechanisms is crucial for managing mucormycosis.

Conclusions:

  • Host immune response plays a critical role in combating mucormycosis.
  • Targeting and enhancing host defense are potential therapeutic strategies.
  • Further research into immune modulation could improve patient outcomes in mucormycosis.